Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
[Autoimmune hepatitis in a patient with multiple sclerosis under treatment with glatiramer acetate].
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Fast Whole-Brain Three-dimensional Macromolecular Proton Fraction Mapping in Multiple Sclerosis.
Restless leg syndrome in different types of demyelinating neuropathies: a single-center pilot study.
Accidental natalizumab administration in pregnancy in multiple sclerosis.
Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression.
Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin.
Picornavirus infection leading to immunosuppression.
Secukinumab: first global approval.
Fingolimod protects cultured cortical neurons against excitotoxic death.
Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease.
Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.
Severe dystonia as the first manifestation of neuromyelitis optica.
JCV test stratifies PML risk in antibody-positive MS
Riluzole attenuates excitatory amino acid transporter type 3 activity in Xenopus oocytes via protein kinase C inhibition.
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
A manual of diseases of the nervous system
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
Electromagnetic Field Stimulation Potentiates Endogenous Myelin Repair by Recruiting Subventricular Neural Stem Cells in an Experimental Model of White Matter Demyelination.
Antinuclear antibodies in pediatric acquired demyelinating diseases of the central nervous system.
Sustained-Release Fampridine (4-Aminopyridine) in Multiple Sclerosis: Efficacy and Impact on Motor Function.

Pages